Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors

Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic that caused serious global emergency. To identify new and effective therapeutics, we employed a drug repurposing approach. The poly (ADP ribose) polymerase inhibitors were used for this purpose and were repurposed against the main pro...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Shailima Rampogu, Tae Sung Jung, Min Woo Ha, Keun Woo Lee
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Nature Portfolio 2023-06-01
Loạt:	Scientific Reports
Truy cập trực tuyến:	https://doi.org/10.1038/s41598-023-36342-7

Những quyển sách tương tự

Virtual screening, molecular docking, molecular dynamics simulations and free energy calculations to discover potential DDX3 inhibitors
Bằng: Shailima Rampogu, et al.
Được phát hành: (2022-07-01)

Explicit molecular dynamics simulation studies to discover novel natural compound analogues as Mycobacterium tuberculosis inhibitors
Bằng: Shailima Rampogu, et al.
Được phát hành: (2023-02-01)

Computational Approaches to Discover Novel Natural Compounds for SARS‐CoV‐2 Therapeutics
Bằng: Dr. Shailima Rampogu, et al.
Được phát hành: (2021-05-01)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 Mpro
Bằng: A. Hussain, et al.
Được phát hành: (2022-04-01)

Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
Bằng: Syed Hani Abidi, et al.
Được phát hành: (2021-05-01)

Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations
Bằng: Shailima Rampogu, et al.
Được phát hành: (2018-03-01)

Correction to: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations
Bằng: Shailima Rampogu, et al.
Được phát hành: (2019-12-01)

Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors
Bằng: Khalid Mashay Alanazi, et al.
Được phát hành: (2021-12-01)

Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
Bằng: Shraddha Parate, et al.
Được phát hành: (2021-03-01)

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease
Bằng: Matthias Göhl, et al.
Được phát hành: (2022-07-01)

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
Bằng: Pietro Delre, et al.
Được phát hành: (2020-11-01)

Inhibitors of SARS-CoV-2 PLpro
Bằng: Dale J. Calleja, et al.
Được phát hành: (2022-04-01)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
Bằng: Alfredo Juárez-Saldívar, et al.
Được phát hành: (2020-11-01)

In Silico Identification of Potential Inhibitors of the SARS-CoV-2 Nucleocapsid Through Molecular Docking-Based Drug Repurposing
Bằng: Rukhsar Afreen, et al.
Được phát hành: (2022-05-01)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
Bằng: Dale J. Calleja, et al.
Được phát hành: (2022-04-01)

Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning
Bằng: Shayan K. Azmoodeh, et al.
Được phát hành: (2022-04-01)

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.
Bằng: Jeremy D Baker, et al.
Được phát hành: (2021-01-01)

Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants
Bằng: Katherine E. Zarn, et al.
Được phát hành: (2022-01-01)

Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants.
Bằng: Katherine E Zarn, et al.
Được phát hành: (2022-01-01)

Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
Bằng: Renata Abel, et al.
Được phát hành: (2020-12-01)

Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
Bằng: Camilla Isgrò, et al.
Được phát hành: (2021-01-01)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method
Bằng: Milan Sencanski, et al.
Được phát hành: (2020-08-01)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
Bằng: Jordi Rodon, et al.
Được phát hành: (2021-03-01)

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
Bằng: Jiri Patocka, et al.
Được phát hành: (2021-03-01)

SARS-CoV-2: Virology and Drug Repurposing Approaches
Bằng: Ratika Rahmasari, et al.
Được phát hành: (2020-07-01)

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
Bằng: Praveen P. N. Rao, et al.
Được phát hành: (2021-01-01)

Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study
Bằng: Ahmad F. Eweas, et al.
Được phát hành: (2022-07-01)

Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
Bằng: Shweta Choudhary, et al.
Được phát hành: (2020-07-01)

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms
Bằng: Ana C. Puhl, et al.
Được phát hành: (2021-03-01)

High throughput screening for SARS-CoV-2 helicase inhibitors
Bằng: Yuka Otsuka, et al.
Được phát hành: (2024-09-01)

A review on the use of machine learning techniques in monkeypox disease prediction
Bằng: Shailima Rampogu
Được phát hành: (2023-01-01)

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease
Bằng: Katarzyna Papaj, et al.
Được phát hành: (2022-01-01)

Evaluation of Xa inhibitors as potential inhibitors of the SARS-CoV-2 Mpro protease.
Bằng: Katarzyna Papaj, et al.
Được phát hành: (2022-01-01)

An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics
Bằng: Shailima Rampogu, et al.
Được phát hành: (2023-02-01)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
Bằng: Nimer Mehyar
Được phát hành: (2023-06-01)

Peroxide derivatives as SARS-CoV-2 entry inhibitors
Bằng: Ding-qi Zhang, et al.
Được phát hành: (2024-02-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
Bằng: Laura Agost-Beltrán, et al.
Được phát hành: (2022-04-01)

Recent insights of SARS-CoV-2 potential inhibitors
Bằng: Mohd Faheem, et al.
Được phát hành: (2022-01-01)

Improved and optimized drug repurposing for the SARS-CoV-2 pandemic.
Bằng: Sarel Cohen, et al.
Được phát hành: (2023-01-01)

SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System
Bằng: Jung Sun Min, et al.
Được phát hành: (2021-08-01)